438190-95-5

Basic information

• Product Name: (5-methyl-pyridin-3-yl)-carbamic acid phenyl ester
• Synonyms: (5-methyl-pyridin-3-yl)-carbamic acid phenyl ester
• CAS NO: 438190-95-5
• Molecular Weight: 228.25
• Mol File: 438190-95-5.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: (5-methyl-pyridin-3-yl)-carbamic acid phenyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: (5-methyl-pyridin-3-yl)-carbamic acid phenyl ester(438190-95-5)
• EPA Substance Registry System: (5-methyl-pyridin-3-yl)-carbamic acid phenyl ester(438190-95-5)

Safety Data

• Hazardous Substances Data: 438190-95-5(Hazardous Substances Data)

Upstream product

• 3430-19-1 5-methylpyridin-3-amine 
• 1885-14-9 phenyl chloroformate 

Downstream Products

• 1020315-43-8 N-(5-methylpyridin-3-yl)-4-(3-{[5-(trifluoromethyl)pyridin-2-yl]oxy}benzylidene)piperidine-1-carboxamide 

Relevant articles and documents

HETEROARYL-SUBSTITUTED SPIROCYCLIC DIAMINE UREA MODULATORS OF FATTY ACID AMIDE HYDROLASE

Certain heteroaryl-substituted spirocyclic diamine urea compounds are described, which are useful as FAAH inhibitors. Such compounds may be used in pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by fatty acid amide hydrolase (FAAH) activity, such as anxiety, pain, inflammation, sleep disorders, eating disorders, energy metabolism disorders, and movement disorders (e.g., multiple sclerosis).

4- [3- (ARYLOXY) BENZYLIDENE] -3-METHYL PIPERIDINE 5-MEMBERED ARYL CARBOXAMIDE COMPOUNDS USEFUL AS FAAH INHIBITORS

The present invention relates to compounds of Formula (I), wherein Ar is a 5-membered heteroaryl moiety and X, Y and Z are independently N or CH; or a pharmaceutically acceptable salt thereof; processes for the preparation of the compounds; intermediates used in the preparation of the compounds; compositions containing the compounds; and uses of the compounds in treating diseases or conditions associated with fatty acid amide hydrolase (FAAH) activity.